Redwood Scientif Stock Price, News & Analysis
Company Description
Redwood Scientif (OTC Link: RSCI) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $14.3M.
RSCI stock has declined 92.6% over the past year. Shares last traded at $0.0111.
This page provides a comprehensive overview of RSCI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Redwood Scientif (RSCI) stock last traded at $0.0111. Over the past 12 months, the stock has lost 92.6%. At a market capitalization of $14.3M, RSCI is classified as a micro-cap stock with approximately 204.2M shares outstanding.
Latest News
Redwood Scientif has 9 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial. View all RSCI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RSCI Company Profile & Sector Positioning
Redwood Scientif (RSCI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing RSCI often look at related companies in the same sector, including Charlottes Web (CWBHF), Integrated Cannabis Solutions (IGPK), Ayr Wellness Inc. (AYRWF), Red Light Hollan (TRUFF), and Argent BioPharma (RGTLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RSCI's relative position within its industry.